Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart.

MLA

Horlock, Duncan, et al. “Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart.” Pharmaceuticals (Basel, Switzerland), vol. 14, no. 3, Mar. 2021. EBSCOhost, https://doi.org/10.3390/ph14030263.

APA

Horlock, D., Kaye, D. M., Winbanks, C. E., Gao, X.-M., Kiriazis, H., Donner, D. G., Gregorevic, P., McMullen, J. R., & Bernardo, B. C. (2021). Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart. Pharmaceuticals (Basel, Switzerland), 14(3). https://doi.org/10.3390/ph14030263

Chicago

Horlock, Duncan, David M Kaye, Catherine E Winbanks, Xiao-Ming Gao, Helen Kiriazis, Daniel G Donner, Paul Gregorevic, Julie R McMullen, and Bianca C Bernardo. 2021. “Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart.” Pharmaceuticals (Basel, Switzerland) 14 (3). doi:10.3390/ph14030263.